Braskem America

Braskem Releases Updated Life Cycle Assessments for I’m green™ Bio-Based Product Line

ROTTERDAM, Netherlands & PHILADELPHIA — Braskem (B3: BRKM3, BRKM5, and BRKM6; NYSE: BAK; LATIBEX: XBRK) has released updated Life Cycle Assessment (LCA) studies for its I’m greenâ„¢ bio-based product portfolio, …

Braskem Releases Updated Life Cycle Assessments for I’m green™ Bio-Based Product Line Read More



Cabaletta Bio

Cabaletta Bio Presents Early Clinical Data From RESET-PV Trial Showing Rese-Cel Activity Without Preconditioning

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) presented initial data from its ongoing RESET-PVâ„¢ trial evaluating rese-cel (resecabtagene autoleucel, formerly CABA-201) in patients with pemphigus vulgaris (PV) during the …

Cabaletta Bio Presents Early Clinical Data From RESET-PV Trial Showing Rese-Cel Activity Without Preconditioning Read More